Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus

Clinical and Vaccine Immunology

Volumn 19, Issue 3, 2012, Pages 396-400

  Smits, Gaby P ^a   Van Gageldonk, Pieter G ^a   Schouls, Leo M ^a   Van Der Klis, Fiona R M ^a   Berbers, Guy A M ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIGEN;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES ZOSTER; HUMAN; IMMUNOASSAY; INSTRUMENT VALIDATION; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MEASLES; MUMPS; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; RUBELLA; SENSITIVITY AND SPECIFICITY;

ADULT; ANTIBODIES, VIRAL; CLINICAL LABORATORY TECHNIQUES; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; MEASLES VIRUS; MICROSPHERES; MUMPS VIRUS; RUBELLA VIRUS; SENSITIVITY AND SPECIFICITY; SERUM;

EID: 84857982297     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05537-11     Document Type: Article

References (21)

1. Biagini RE, et al. 2003. Method for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharides. Clin. Diagn. Lab. Immunol. 10:744 -750.
2. de Haas R, van den Hof S, Berbers GA, de Melker HE, Conyn-van Spaendonck MA. 1999. Prevalence of antibodies against rubella virus in The Netherlands 9 years after changing from selective to mass vaccination. Epidemiol. Infect. 123:263-270. (Pubitemid 29509324)
3. De Melker HE, Conyn-van Spaendonck MA. 1998. Immunosurveillance and the evaluation of national immunization programmes: a population-based approach. Epidemiol. Infect. 121:637-643. (Pubitemid 29023043)
4. de Voer RM, et al. 2008. Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides. Clin. Vaccine Immunol. 15:1188-1193.
5. Dhiman N, et al. 2010. Detection of IgG-class antibodies to measles, mumps, rubella, and varicella-zoster virus using a multiplex bead immunoassay. Diagn. Microbiol. Infect. Dis. 67:346-349.
6. Elberse KE, Tcherniaeva I, Berbers GA, Schouls LM. 2010. Optimization and application of a multiplex bead-based assay to quantify serotype-specific IgG against Streptococcus pneumoniae polysaccharides: response to the booster vaccine after immunization with the pneumococcal 7-valent conjugate vaccine. Clin. Vaccine Immunol. 17:674-682.
7. EMEA. 1995. ICH topic Q2 (R1) validation of analytical procedures: text and methodology. Note for guidance on validation of analytical procedures: text and methodology. Report CGMP/ICH/381/95. EMEA, London, United Kingdom.
8. Gans HA, et al. 2004. T cell immunity to measles viral proteins in infants and adults after measles immunization. Viral Immunol. 17:298-307. (Pubitemid 38880429)
9. Hahne S, et al. 2009. Rubella outbreak in The Netherlands, 2004-2005: high burden of congenital infection and spread to Canada. Pediatr. Infect. Dis. J. 28:795-800.
10. Harmsen T, et al. 1992. Comparison of a neutralization enzyme immunoassay and an enzyme-linked immunosorbent assay for evaluation of immune status of children vaccinated for mumps. J. Clin. Microbiol. 30: 2139-2144.
11. Karagiannis I, et al. 2008. Mumps in a community with low vaccination coverage in the Netherlands. Euro Surveill. 13(25):pii=18906.
12. Lal G, et al. 2005. Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes. J. Immunol. Methods 296:135-147. (Pubitemid 40174747)
13. Opalka D, et al. 2003. Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed Luminex assay. Clin. Diagn. Lab. Immunol. 10:108-115. (Pubitemid 36133838)
14. Staros JV, Wright RW, Swingle DM. 1986. Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal. Biochem. 156:220-222. (Pubitemid 16044423)
15. van den Hof S, Beaumont MT, Berbers GA, de Melker HE. 2003. Antibodies against mumps in The Netherlands as assessed by indirect ELISA and virus neutralization assay. Epidemiol. Infect. 131:703-709. (Pubitemid 37062892)
16. van den Hof S, Berbers GA, de Melker HE, Conyn-van Spaendonck MA. 1999. Sero-epidemiology of measles antibodies in The Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage. Vaccine 18:931-940.
17. van den Hof S, et al. 2001. Measles outbreak in a community with very low vaccine coverage, The Netherlands. Emerg. Infect. Dis. 7:593-597.
18. van der Klis FR, Mollema L, Berbers GA, de Melker HE, Coutinho RA. 2009. Second national serum bank for population-based seroprevalence studies in The Netherlands. Neth. J. Med. 67:301-308.
19. van Gageldonk PG, van Schaijk FG, van der Klis FR, Berbers GA. 2008. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus. J. Immunol. Methods 335:79-89.
20. van Lier EA, et al. 2009. High vaccination coverage of the National Immunization Programme in The Netherlands. Ned. Tijdschr. Geneeskd. 153:950-957. (In Dutch.)
21. Waterboer T, Sehr P, Pawlita M. 2006. Suppression of non-specific binding in serological Luminex assays. J. Immunol. Methods 309:200-204. (Pubitemid 43190816)